• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症患者脑脊液的脂质谱:一种潜在的诊断工具。

Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis.

机构信息

Universitat de Lleida (UdL), Lleida, Spain.

Institut de Recerca Biomèdica de Lleida (IRB-Lleida), Lleida, Spain.

出版信息

Sci Rep. 2019 Aug 5;9(1):11313. doi: 10.1038/s41598-019-47906-x.

DOI:10.1038/s41598-019-47906-x
PMID:31383928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6683197/
Abstract

Multiple sclerosis (MS) is a complex multifactorial neuropathology. Although its etiology remains unclear, it has been demonstrated that the immune system attacks myelin, leading to demyelination and axonal damage. The involvement of lipids as one of the main components of myelin sheaths in MS and other demyelinating diseases has been postulated. However, it is still a matter of debate whether specific alteration patterns exist over the disease course. Here, using a lipidomic approach, we demonstrated that, at the time of diagnosis, the cerebrospinal fluid of MS patients presented differences in 155 lipid species, 47 of which were identified. An initial hierarchical clusterization was used to classify MS patients based on the presence of 25 lipids. When a supervised method was applied in order to refine this classification, a lipidomic signature was obtained. This signature was composed of 15 molecules belonging to five different lipid families including fatty acids (FAs). An FA-targeted approach revealed differences in two members of this family: 18:3n3 and 20:0 (arachidic acid). These results reveal a CSF lipidomic signature in MS patients at the time of diagnosis that might be considered as a potential diagnostic tool.

摘要

多发性硬化症(MS)是一种复杂的多因素神经病理学。尽管其病因仍不清楚,但已经证明免疫系统攻击髓鞘,导致脱髓鞘和轴突损伤。脂质作为髓鞘的主要成分之一参与多发性硬化症和其他脱髓鞘疾病已经被假设。然而,在疾病过程中是否存在特定的改变模式仍存在争议。在这里,我们使用脂质组学方法表明,在诊断时,MS 患者的脑脊液中存在 155 种脂质种类的差异,其中 47 种已被鉴定。最初使用层次聚类法根据 25 种脂质的存在来对 MS 患者进行分类。当应用监督方法来完善这种分类时,获得了一个脂质组学特征。该特征由属于五个不同脂质家族的 15 种分子组成,包括脂肪酸(FAs)。FA 靶向方法揭示了该家族中两个成员的差异:18:3n3 和 20:0(花生四烯酸)。这些结果揭示了 MS 患者在诊断时的脑脊液脂质组学特征,可被视为一种潜在的诊断工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce28/6683197/6379cf3aa166/41598_2019_47906_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce28/6683197/cfc4401d0aaa/41598_2019_47906_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce28/6683197/6379cf3aa166/41598_2019_47906_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce28/6683197/cfc4401d0aaa/41598_2019_47906_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce28/6683197/6379cf3aa166/41598_2019_47906_Fig2_HTML.jpg

相似文献

1
Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis.多发性硬化症患者脑脊液的脂质谱:一种潜在的诊断工具。
Sci Rep. 2019 Aug 5;9(1):11313. doi: 10.1038/s41598-019-47906-x.
2
Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain-Barré syndrome.多发性硬化症和吉兰-巴雷综合征脱髓鞘的脑脊液脂质组学生物标志物特征。
Sci Rep. 2020 Oct 27;10(1):18380. doi: 10.1038/s41598-020-75502-x.
3
Comparative targeted lipidomics between serum and cerebrospinal fluid of multiple sclerosis patients shows sex and age-specific differences of endocannabinoids and glucocorticoids.多发性硬化症患者血清和脑脊液的靶向脂质组学比较显示内源性大麻素和糖皮质激素存在性别和年龄特异性差异。
Acta Neuropathol Commun. 2024 Oct 10;12(1):160. doi: 10.1186/s40478-024-01864-2.
4
Multiple sclerosis has a distinct lipid signature in plasma and cerebrospinal fluid.多发性硬化症在血浆和脑脊液中具有独特的脂质特征。
Arq Neuropsiquiatr. 2019 Oct 24;77(10):696-704. doi: 10.1590/0004-282X20190122. eCollection 2019.
5
Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism.脂质组学分析多发性硬化症揭示了蛋白质脂质氧化损伤作为潜在的发病机制。
J Neurochem. 2012 Nov;123(4):622-34. doi: 10.1111/j.1471-4159.2012.07934.x. Epub 2012 Sep 28.
6
Altered Cerebrospinal Fluid Concentrations of Hydrophobic and Hydrophilic Compounds in Early Stages of Multiple Sclerosis-Metabolic Profile Analyses.多发性硬化症早期改变的脑脊髓液疏水性和亲水性化合物浓度-代谢谱分析。
J Mol Neurosci. 2019 Sep;69(1):94-105. doi: 10.1007/s12031-019-01336-6. Epub 2019 May 27.
7
[The fatty acid profile of cerebrospinal fluid lipids in demyelinating disorders].[脱髓鞘疾病中脑脊液脂质的脂肪酸谱]
Z Neurol. 1970;198(2):223-36.
8
An overview of lipidomic analysis in different human matrices of multiple sclerosis.多发性硬化症不同人体基质中脂质组学分析概述
Mult Scler Relat Disord. 2020 Sep;44:102189. doi: 10.1016/j.msard.2020.102189. Epub 2020 May 29.
9
Sulfatide isoform pattern in cerebrospinal fluid discriminates progressive MS from relapsing-remitting MS.脑脊液硫酸脑苷脂同种型模式可区分进展型多发性硬化与复发缓解型多发性硬化。
J Neurochem. 2018 Aug;146(3):322-332. doi: 10.1111/jnc.14452. Epub 2018 Jul 3.
10
Cerebrospinal fluid lipids in demyelinating disease. I. Sphingolipids.脱髓鞘疾病中的脑脊液脂质。I. 鞘脂类
J Neurol. 1980 Jan;222(3):171-6. doi: 10.1007/BF00313115.

引用本文的文献

1
Demyelination and Remyelination: General Principles.脱髓鞘与再髓鞘化:一般原则
Adv Neurobiol. 2025;43:207-255. doi: 10.1007/978-3-031-87919-7_9.
2
Metabolomics: a new frontier in neurodegenerative disease biomarker discovery.代谢组学:神经退行性疾病生物标志物发现的新前沿。
Metabolomics. 2025 May 15;21(3):67. doi: 10.1007/s11306-025-02267-7.
3
Phospholipids and Sphingolipids in Osteoarthritis.骨关节炎中的磷脂和鞘脂

本文引用的文献

1
Impact of the 2017 revisions to McDonald criteria on the diagnosis of multiple sclerosis.2017年对麦克唐纳标准的修订对多发性硬化症诊断的影响。
Mult Scler. 2018 Nov;24(13):1786-1787. doi: 10.1177/1352458518778007. Epub 2018 May 15.
2
Progress in understanding the pathophysiology of multiple sclerosis.多发性硬化症病理生理学研究进展。
Rev Neurol (Paris). 2018 Jun;174(6):358-363. doi: 10.1016/j.neurol.2018.03.006. Epub 2018 Apr 19.
3
Phosphatidylcholine 36:1 concentration decreases along with demyelination in the cuprizone animal model and in post-mortem multiple sclerosis brain tissue.
Biomolecules. 2025 Feb 8;15(2):250. doi: 10.3390/biom15020250.
4
Myelin Lipid Alterations in Neurodegenerative Diseases: Landscape and Pathogenic Implications.神经退行性疾病中的髓磷脂脂质改变:概况与致病意义
Antioxid Redox Signal. 2024 Dec;41(16-18):1073-1099. doi: 10.1089/ars.2024.0676. Epub 2024 Nov 22.
5
Recent Advances in Metabolomics and Lipidomics Studies in Human and Animal Models of Multiple Sclerosis.多发性硬化症人类和动物模型中代谢组学和脂质组学研究的最新进展
Metabolites. 2024 Oct 13;14(10):545. doi: 10.3390/metabo14100545.
6
CSF sphingolipids are correlated with neuroinflammatory cytokines and differentiate neuromyelitis optica spectrum disorder from multiple sclerosis.脑脊液鞘脂与神经炎症细胞因子相关,并可将视神经脊髓炎谱系障碍与多发性硬化症区分开来。
J Neurol Neurosurg Psychiatry. 2024 Dec 16;96(1):54-67. doi: 10.1136/jnnp-2024-333774.
7
Nutritional roles and therapeutic potentials of dietary sphingomyelin in brain diseases.膳食鞘磷脂在脑部疾病中的营养作用及治疗潜力
J Clin Biochem Nutr. 2024 May;74(3):185-191. doi: 10.3164/jcbn.23-97. Epub 2023 Dec 26.
8
Plasma Lipidomic Profiling Using Mass Spectrometry for Multiple Sclerosis Diagnosis and Disease Activity Stratification (LipidMS).使用质谱法进行血浆脂质组分析以用于多发性硬化症诊断和疾病活动分层(脂质质谱分析)
Int J Mol Sci. 2024 Feb 20;25(5):2483. doi: 10.3390/ijms25052483.
9
Metabolomics of Cerebrospinal Fluid Amino and Fatty Acids in Early Stages of Multiple Sclerosis.多发性硬化症早期脑脊液氨基酸和脂肪酸的代谢组学研究。
Int J Mol Sci. 2023 Nov 13;24(22):16271. doi: 10.3390/ijms242216271.
10
Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis.多发性硬化症中少突胶质细胞和髓鞘能量代谢的改变。
Int J Mol Sci. 2023 Aug 18;24(16):12912. doi: 10.3390/ijms241612912.
在杯状病毒动物模型和多发性硬化症死后脑组织中,磷脂酰胆碱 36:1 浓度随着脱髓鞘而降低。
J Neurochem. 2018 Jun;145(6):504-515. doi: 10.1111/jnc.14335. Epub 2018 Jun 10.
4
Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome.脂质组学揭示甘油磷脂生物合成途径和细胞信号转导的改变作为多囊卵巢综合征的生物标志物。
Oncotarget. 2017 Dec 17;9(4):4522-4536. doi: 10.18632/oncotarget.23393. eCollection 2018 Jan 12.
5
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.多发性硬化症的诊断:2017 年麦当劳标准修订版。
Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21.
6
Polyunsaturated fatty acids and the risk of multiple sclerosis.多不饱和脂肪酸与多发性硬化症风险。
Mult Scler. 2017 Dec;23(14):1830-1838. doi: 10.1177/1352458517691150. Epub 2017 Feb 3.
7
Diagnosis of multiple sclerosis: progress and challenges.多发性硬化症的诊断:进展与挑战。
Lancet. 2017 Apr 1;389(10076):1336-1346. doi: 10.1016/S0140-6736(16)30959-X. Epub 2016 Nov 24.
8
White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.脑老化女性白质脂质作为生酮供能物质:对阿尔茨海默病的影响。
EBioMedicine. 2015 Nov 3;2(12):1888-904. doi: 10.1016/j.ebiom.2015.11.002. eCollection 2015 Dec.
9
Alpha-methylacyl-CoA racemase deletion has mutually counteracting effects on T-cell responses, associated with unchanged course of EAE.α-甲基酰基辅酶 A 消旋酶缺失对 T 细胞反应有相互拮抗的影响,与 EAE 的病程不变有关。
Eur J Immunol. 2016 Mar;46(3):570-81. doi: 10.1002/eji.201545782. Epub 2016 Jan 22.
10
Lipidomics of human brain aging and Alzheimer's disease pathology.人脑衰老与阿尔茨海默病病理学的脂质组学
Int Rev Neurobiol. 2015;122:133-89. doi: 10.1016/bs.irn.2015.05.008. Epub 2015 Jun 19.